Biosimilars Archives - Express Pharma

Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions

Amneal completes Kashiv BioSciences acquisition

Redrawing the biopharma map: India’s rise in the biosimilars era

India at a jumping-off point in terms of commitment to global clinical studies

Can Indian biosimilars and generics restate accessibility in global underserved markets?

India’s biopharma industry charts the road from biosimilars to innovation

Industry experts respond to FDA move to streamline biosimilar development

Lupin signs license and supply agreement with Zentiva for commercialising Certolizumab

Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData

Alvotech and Dr Reddy’s Laboratories partner to develop biosimilar for Keytruda targeting global markets